These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1977444)

  • 1. Bifunctional chelating agents for radiometal-labeled monoclonal antibodies.
    Subramanian R; Meares CF
    Cancer Treat Res; 1990; 51():183-99. PubMed ID: 1977444
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel bifunctional linkers for antibody chelation with radiometals.
    Wu RS
    Cancer Treat Res; 1990; 51():215-32. PubMed ID: 1977446
    [No Abstract]   [Full Text] [Related]  

  • 3. Chelates and antibodies: current methods and new directions.
    Gansow OA; Brechbiel MW; Mirzadeh S; Colcher D; Roselli M
    Cancer Treat Res; 1990; 51():153-71. PubMed ID: 1977442
    [No Abstract]   [Full Text] [Related]  

  • 4. Clickable bifunctional radiometal chelates for peptide labeling.
    Lebedev AY; Holland JP; Lewis JS
    Chem Commun (Camb); 2010 Mar; 46(10):1706-8. PubMed ID: 20177623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of N-[tris[2-[[N-(benzyloxy)amino]carbonyl]ethyl]methyl]succinamic acid, trisuccin. Hydroxamic acid derivatives as a new class of bifunctional chelating agents.
    Safavy A; Buchsbaum DJ; Khazaeli MB
    Bioconjug Chem; 1993; 4(3):194-8. PubMed ID: 8324008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc labeling of proteins: initial evaluation of a novel diaminedithiol bifunctional chelating agent.
    Baidoo KE; Scheffel U; Lever SZ
    Cancer Res; 1990 Feb; 50(3 Suppl):799s-803s. PubMed ID: 2297727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioimmunodetection of a tumor with Ga-67 labeled antibodies: effect of radiolabeling on antibody activities].
    Furukawa T; Endo K; Ohmomo Y; Sakahara H; Koizumi M; Nakashima T; Fukunaga M; Morita R; Hirai H; Yokoyama A
    Kaku Igaku; 1986 Apr; 23(4):337-43. PubMed ID: 3735781
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peroperative isotope detection].
    Proye C; Marchandise X
    Ann Chir; 1990; 44(6):423-5. PubMed ID: 2221786
    [No Abstract]   [Full Text] [Related]  

  • 9. Methods to label monoclonal antibodies for use in tumor imaging.
    Otsuka FL; Welch MJ
    Int J Rad Appl Instrum B; 1987; 14(3):243-9. PubMed ID: 3312119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.
    Deshpande SV; DeNardo SJ; Kukis DL; Moi MK; McCall MJ; DeNardo GL; Meares CF
    J Nucl Med; 1990 Apr; 31(4):473-9. PubMed ID: 2324823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour localisation with monoclonal antibody radioactivity labelled with metal chelate rather than iodine.
    Rainsbury R; Westwood J
    Lancet; 1982 Dec; 2(8311):1347-8. PubMed ID: 6128634
    [No Abstract]   [Full Text] [Related]  

  • 12. Labeling of anti-tumor antibodies and antibody fragments with Tc-99m.
    Hansen HJ; Jones AL; Grebenau R; Kunz A; Goldenberg DM
    Cancer Treat Res; 1990; 51():233-44. PubMed ID: 1977447
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiolabeling antibodies via the cyclic anhydride of DTPA--experiences of 5 years.
    Hnatowich DJ
    Cancer Treat Res; 1990; 51():173-81. PubMed ID: 1977443
    [No Abstract]   [Full Text] [Related]  

  • 14. Labelling monoclonal antibodies with macrocyclic radiometal complexes. A challenge for coordination chemists.
    Kaden TA
    Dalton Trans; 2006 Aug; (30):3617-23. PubMed ID: 16865171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity.
    Kozak RW; Raubitschek A; Mirzadeh S; Brechbiel MW; Junghans RP; Gansow OA; Waldmann TA
    Cancer Res; 1989 May; 49(10):2639-44. PubMed ID: 2785435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin.
    Mirzadeh S; Brechbiel MW; Atcher RW; Gansow OA
    Bioconjug Chem; 1990; 1(1):59-65. PubMed ID: 2095205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoimaging with 99mTc monoclonal antibodies: clinical studies.
    Morrison RT; Lyster DM; Alcorn L; Rhodes BA; Breslow K; Burchiel SW
    Int J Nucl Med Biol; 1984; 11(2):184-8. PubMed ID: 6480262
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
    Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
    Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy.
    Larson SM
    J Nucl Med; 1985 May; 26(5):538-45. PubMed ID: 3989608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labeling of monoclonal antibodies with radionuclides.
    Bhargava KK; Acharya SA
    Semin Nucl Med; 1989 Jul; 19(3):187-201. PubMed ID: 2503873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.